OOIR: Observatory of International Research

Papers

(The H4-Index of International Journal of Pharmaceutics is 52. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-06-01 to 2025-06-01.)

Article	Citations
Editorial Board	246
Levilactobacillus brevis surface layer protein B promotes liposome targeting to antigen-presenting cells in Peyer’s patches	184
Effect of the combination of permeation enhancer and ion-pairs strategies on transdermal delivery of tofacitinib	128
Towards catch-up therapy: evaluation of nucleophilic active pharmaceutical ingredients for the treatment of percutaneous VX poisoning, in-vial and in-vitro studies	127
Effects of particle size and release property of paclitaxel-loaded nanoparticles on their peritoneal retention and therapeutic efficacy against mouse malignant ascites	125
Editorial Board	121
Practical use of primary drying models in an industrial environment with limited availability of equipment sensors	105
Design of red blood cell membrane-cloaked dihydroartemisinin nanoparticles with enhanced antimalarial efficacy	101
In vivo methodologies to assist preclinical development of topical fixed-dose combinations for pain management	101
Synergistic therapy with celastrol-curcumin multifunctional nanomedicine: Anti-hepatocellular carcinoma and reduced hepatotoxicity	100
Corrigendum to article “Clotrimazole nanoemulsion for malaria chemotherapy. Part II: Stability assessment, in vivo pharmacodynamic evaluations and toxicological studies” [Int. J. Pharm. 431(1–2) (2012	96
Corrigendum to “Mechanistic modeling of twin screw wet granulation for pharmaceutical formulations: Calibration, sensitivity analysis, and model-driven workflow” [Int. J. Pharm. 659 (2024) 124246]	92
Switching from batch to continuous granulation: A case study of metoprolol succinate ER tablets	87
Corrigendum to “Investigation on hot melt extrusion and prediction on 3D printability of pharmaceutical grade polymers” [Int. J. Pharm. 604 (2021) 120755]	84
Evaluation of immune-modulating drugs for use in drug-eluting microsphere transarterial embolization	84
Corrigendum to “Microparticulated Polygonatum sibiricum polysaccharide shows potent vaccine adjuvant effect” [Int. J. Pharm. 652 (2024) 123802]	82
Biomimetic replenishment therapy of cortisol using semi-solid extrusion – 3D printed tablets for adrenal insufficiencies	82
In vivo and in vitro transdermal availability of Ibuprofen using novel solubility enhancing fluid nanosized carrier systems	81
Characterization and bioavailability of a novel coenzyme Q10 nanoemulsion used as an infant formula supplement	80
Elastic cationic liposomes for vitamin C delivery: Development, characterization and skin absorption study	77
A quantification of gastric and duodenal fluid volumes in older adults using MRI	74
Vesicular phospholipid gels: A new strategy to improve topical antimicrobial dermatotherapy	73
From laminar to turbulent flow in a dry powder inhaler: The effect of simple design modifications	73
Novel microparticulate Zika vaccine induces a significant immune response in a preclinical murine model after intramuscular administration	73
A framework to optimize spring-driven autoinjectors	72

Development of a nanocapsule-loaded hydrogel for drug delivery for intraperitoneal administration	70
Efficacy and safety of nanoparticles of glibenclamide and organomodified layered double hydroxides in diabetics rats	69
Predictive modeling for assessing the long-term thermal stability of a new fully-liquid quadrivalent meningococcal tetanus toxoid conjugated vaccine	68
Wet granulation end point prediction using dimensionless numbers in a mixer torque rheometer: Relationship between capillary and Weber numbers and the optimal wet mass consistency	67
(E, E)-farnesol and myristic acid-loaded lipid nanoparticles overcome colistin resistance in Acinetobacter baumannii	67
A straw for paediatrics: How to administer highly dosed, bitter tasting paracetamol granules	66
Protective role of transforming growth factor-Β3 (TGF-Β3) in the formation of radiation-induced capsular contracture around a breast implant: In vivo experimental study	66
Evaluation of a polymeric topical formulation of Endoxifen in an estrogen receptor positive breast cancer murine model	66
Comparative dissolution studies of 3D-printed inserts in a novel biopharmaceutical bladder model	65
Hyaluronic acid-functionalized DDAB/PLGA nanoparticles for improved oral delivery of magnolol in the treatment of ulcerative colitis	65
Editorial Board	65
Tumor-specific targeting of polymer drug delivery systems with recombinant proteins bound via tris(nitrilotriacetic acid)	65
Dry powder inhaler formulation comparison: Study of the role of particle deposition pattern and dissolution	65
Editorial Board	64
DNA-templated nanosheets for enhanced chemodynamic therapy and gene therapy to inhibit tumor recurrence and metastasis	62
Increased bioavailability of a P-gp substrate: Co-release of etoposide and zosuquidar from amorphous solid dispersions	62
Enhanced dissolution rate of nimodipine through β-lactoglobulin based formulation	61
Tumor microenvironment stimuli-responsive lipid-drug conjugates for cancer treatment	60
Targeted treatment of triple-negative-breast cancer through pH-triggered tumour associated macrophages using smart theranostic nanoformulations	60
An improved experimental model of osteosarcoma lung metastases to investigate innovative therapeutic interventions and sex as a biological variable	60
F3 peptide functionalized liquid crystalline nanoparticles for delivering Salinomycin against breast cancer	59
Glatiramer acetate enhances tumor retention and innate activation of immunostimulants	59
Exploiting inhalable microparticles incorporating hybrid polymer-lipid nanoparticles loaded with Iloprost manages lung hyper-inflammation	59
A compartment model for subcutaneous injection of monoclonal antibodies	58
Heme oxygenase 1 inhibitor discovery and formulation into nanostructured lipid carriers as potent and selective treatment against triple negative metastatic breast cancer	56
Simultaneous modeling prediction of three key quality attributes of tablets by powder physical properties	54
Tablet diversion strategy based on in-line NIR tablet press feed frame measurements	53
The application of Near-Infrared Spatially Resolved Spectroscopy in scope of achieving continuous real-time quality monitoring and control of tablets with challenging dimensions	52
Lyophilized liposomal formulation of a peptidomimetic-Dox conjugate for HER2 positive breast and lung cancer	52
Calreticulin P-domain-derived “Eat-me” peptides for enhancing liposomal uptake in dendritic cells	52